Abstract
Background. Long-standing aortic stenosis (AS) causes significant progressive left ventricular dysfunction and may result in subendocardial ischaemia and conduction disorders. Though stentless bioprosthesis show better haemodynamic profiles compared with stented, yet debate exists about the differential effects of valve substitutes on the incidence of permanent pacemaker (PPM) implantation following aortic valve replacement (AVR).
Methods. 510 consecutive patients aged 65–77 years with predominant AS accepted for isolated non-emergent AVR (360 received stented and 150 stentless) were studied over three years period. A stepwise logistic regression analysis was used and statistical significance was accepted at P < 0.05.
Results. Mean age ± standard deviation for the stented group was 70.43 ± 7.2 and the stentless was 61.7 ± 12.3. Perioperative (30-day) mortality was 1% (5 of the 510 patients). Smaller aortic prosthesis size was identified as a significant predictors of hospital mortality [univariate and multivariate analysis (P < 0.05)]. Risk factors identified for PPM by univariate analysis were: preoperative: age, left atrial enlargement (LAE), MI, left bundle branch block (LBBB), poor ejection fraction < 35% (P < 0.05), postoperative; bypass time > 100 min with x-clamp time > 70 min, concomitant aortic surgery and prosthetic valve size ≤ 21 mm (P < 0.05). Multivariate analysis identified the preoperative MI (P = 0.003), poor ejection fraction < 35% (P = 0.007), LAE, (P = 0.001) and LBBB (P = 0.002), the perioperative variables; bypass time > 100 min with x-clamp time > 70 min (P < 0.001) and prosthetic valve size ≤ 21 mm (P = 0.003). Test of interaction analysis identified valve type as an important predictor of PPM (P = 0.01)
Conclusions. The results demonstrated that where stentless valves required longer bypass and cross clamp times, more stented valves were small (< 21 mm, P < 0.05). In précis, this suggests that prevalence of PPM seems to be dependent on the size and type of bioprosthesis used in patients undergoing isolated AVR and this incidence of PPM is twice in stentless group (18% vs. 9.1%, P = 0.01).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of congestive heart failure in patients aged > or = 62 years with unoperated seveer valvualr aortic stenosis. Am J Cardiol 1993;72:846–848.
Gordon RS, Ivanov J, Cohen G, Ralph-Edwards AL. Permanent cardiac pacing after a cardiac operation: Predicting the use of permanent pacemakers. Ann Thorac Surg 1998;66:1698–1704.
Del Rizzo DF, Nishimura S, Lau C, Sever J, Goldman BS. Cardiac pacing following surgery for acquired heart disease. J Card Surg 1996;11:332–340.
Limongelli G, Ducceschi V, D’Andrea A, Renzulli A et al. Risk factors for pacemaker implantation following aortic valve replacement: A single centre experience. Heart 2003;89:901–904.
Baur LHB, Bootsma M, Braum J, Kappetein AP, Bruschke AVG, Huysmans HA. Left ventricular remodelling after aortic valve replacement with a stentless biprosthesis. Cardiovasc Imaging 1999;11:21–24.
Collinson J, Henein M, Flather M, Gibson DG, Pepper JR. Valve replacement for aortic stenosis in patients with poor left ventricular function: Comparison of early changes with steneted and non-stented valves. Circulation 1999;100:1–5.
Jin XY, Westaby S, Gibson DG, Pillai R, Taggart DP. Left ventricular remodelling and improvement in freestyle stentless valve haemodynamics. Eur J Cardiothoracic Surg 1997;12:63–69.
Collinson J, Flather M, Coats AJ, Pepper JR, Henein M. Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosis. Int J Cardiol 2004;97:535–541.
Villari B, Vassalli G, Monrad ES, Chiariello M, Turina M, Hess OM. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation 1995;91:2353–2358.
Villari B, Vassalli G, Betocchi S, Briguori C, Chiariello M, Hess OM. Normalization of left ventricular nonuniformity late after valve replacement for aortic stenosis. Am J Cardiol 1996;78:66– 71.
Willems JL, Robles de Medina EO, Bernard R, Coumel P, Fisch C, Krikler D, Mazur NA, Meijler FL, Mogensen L, Moret P. Criteria for intraventricular conduction disturbances and preexcitation. J Am Coll Cardiol 1985;5:1261–1275.
Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 GuidelineUpdate for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002;40: 1703–1719.
Ennker J, Rosendahl U, Albert A, Dumlu E, Ennker IC, Florath I. Stentless bioprostheses in small aortic roots: Impact of patient-prosthesis mismatch on survival and quality of life. J Heart Valve Dis 2005;14:523–530.
ElKhally Z, Thibault B, Staniloae C, Theroux P, Dubuc M, Roy D, Guerra P, Macle L, Talajic M. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am J Cardiol 2004;94:1008–1011.
Boughaleb D, Mansourati J, Genet L, Barra J, Mondine P, Blanc JJ. Permanent cardiac stimulation after aortic valve replacement: Incidence, predictive factors and long-term prognosis. Arch Mal Coeur Vaiss 1994;87:925–930.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elahi, M., Usmaan, K. The bioprosthesis type and size influence the postoperative incidence of permanent pacemaker implantation in patients undergoing aortic valve surgery. J Interv Card Electrophysiol 15, 113–118 (2006). https://doi.org/10.1007/s10840-006-7750-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10840-006-7750-4